| DIRECT COMPETITOR COMPARISON | |
| AOB | Pvt1 | Pvt2 | Pvt3 | Industry | | Market Cap: | 314.07M | N/A | N/A | N/A | 104.07M | | Employees: | 4,076 | 2501 | 2,3451 | 2,4111 | 68 | | Qtrly Rev Growth (yoy): | 11.70% | N/A | N/A | N/A | 19.70% | | Revenue (ttm): | 292.39M | 60.70M1 | 186.00M1 | 2.41B1 | 14.01M | | Gross Margin (ttm): | 59.34% | N/A | N/A | N/A | 65.67% | | EBITDA (ttm): | 79.82M | N/A | N/A | N/A | -12.30M | | Oper Margins (ttm): | 23.16% | N/A | N/A | N/A | -149.46% | | Net Income (ttm): | 37.58M | N/A | 58.10M1 | 18.90M1 | N/A | | EPS (ttm): | 0.494 | N/A | N/A | N/A | -0.33 | | P/E (ttm): | 8.12 | N/A | N/A | N/A | 16.37 | | PEG (5 yr expected): | 0.97 | N/A | N/A | N/A | 1.31 | | P/S (ttm): | 1.07 | N/A | N/A | N/A | 9.43 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.35 | 0.00% | 57.03B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.94 | 0.00% | 13.57B | 15.71 | | Genzyme Corp. | GENZ | 50.70 | 0.00% | 13.45B | 28.91 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.11 | 0.00% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | 0.00% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | 0.00% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.09 | 0.00% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | 0.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.87 | 0.00% | 5.46B | 109.63 | | Pfizer Inc. | PFE | 18.17 | 0.00% | 146.62B | 15.09 | | Johnson & Johnson | JNJ | 62.84 | 0.00% | 173.38B | 13.72 | | GlaxoSmithKline plc | GSK | 41.47 | 0.00% | 105.13B | 13.17 | | Sanofi-Aventis | SNY | 37.96 | 0.00% | 99.12B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.60 | 0.00% | 126.28B | 16.65 | | RHHBY.PK | 40.92 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 44.83 | 0.00% | 65.00B | 9.00 | | Abbott Laboratories | ABT | 54.49 | 0.00% | 84.28B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 25.31 | 0.00% | 50.14B | 13.09 |
|
| NEWS ON DIRECT COMPETITORS | |
No News on Direct Competitors |
|
|
0.34% Nasdaq 0.00%
Competitors
